X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with Piramal Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs PIRAMAL ENTERPRISES - Comparison Results

BIOCON      Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON PIRAMAL ENTERPRISES BIOCON /
PIRAMAL ENTERPRISES
 
P/E (TTM) x 19.3 28.1 68.7% View Chart
P/BV x 3.0 1.3 241.5% View Chart
Dividend Yield % 0.4 1.4 27.0%  

Financials

 BIOCON    PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    BIOCON
Mar-18
PIRAMAL ENTERPRISES
Mar-19
BIOCON /
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs1,1883,303 36.0%   
Low Rs3051,797 17.0%   
Sales per share (Unadj.) Rs68.7716.5 9.6%  
Earnings per share (Unadj.) Rs7.679.7 9.5%  
Cash flow per share (Unadj.) Rs14.0107.9 12.9%  
Dividends per share (Unadj.) Rs1.0028.00 3.6%  
Dividend yield (eoy) %0.11.1 12.2%  
Book value per share (Unadj.) Rs86.31,477.5 5.8%  
Shares outstanding (eoy) m600.00184.45 325.3%   
Bonus/Rights/Conversions ISIS-  
Price / Sales ratio x10.93.6 305.2%   
Avg P/E ratio x98.932.0 309.0%  
P/CF ratio (eoy) x53.423.6 226.1%  
Price / Book Value ratio x8.61.7 501.0%  
Dividend payout %13.235.1 37.7%   
Avg Mkt Cap Rs m447,900470,292 95.2%   
No. of employees `0006.17.8 78.6%   
Total wages/salary Rs m9,31122,504 41.4%   
Avg. sales/employee Rs Th6,705.816,899.4 39.7%   
Avg. wages/employee Rs Th1,514.22,877.7 52.6%   
Avg. net profit/employee Rs Th736.91,879.9 39.2%   
INCOME DATA
Net Sales Rs m41,234132,153 31.2%  
Other income Rs m2,0623,128 65.9%   
Total revenues Rs m43,296135,281 32.0%   
Gross profit Rs m8,29166,290 12.5%  
Depreciation Rs m3,8515,202 74.0%   
Interest Rs m61544,097 1.4%   
Profit before tax Rs m5,88720,119 29.3%   
Minority Interest Rs m2133,194 6.7%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5698,611 18.2%   
Profit after tax Rs m4,53114,701 30.8%  
Gross profit margin %20.150.2 40.1%  
Effective tax rate %26.742.8 62.3%   
Net profit margin %11.011.1 98.8%  
BALANCE SHEET DATA
Current assets Rs m41,486122,742 33.8%   
Current liabilities Rs m21,413310,810 6.9%   
Net working cap to sales %48.7-142.3 -34.2%  
Current ratio x1.90.4 490.6%  
Inventory Days Days6423 277.3%  
Debtors Days Days9439 242.5%  
Net fixed assets Rs m50,661116,904 43.3%   
Share capital Rs m3,000369 813.2%   
"Free" reserves Rs m48,808272,161 17.9%   
Net worth Rs m51,808272,530 19.0%   
Long term debt Rs m17,898270,196 6.6%   
Total assets Rs m99,897856,261 11.7%  
Interest coverage x10.61.5 726.0%   
Debt to equity ratio x0.31.0 34.8%  
Sales to assets ratio x0.40.2 267.4%   
Return on assets %5.26.9 75.0%  
Return on equity %8.75.4 162.1%  
Return on capital %9.612.4 77.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m12,05815,200 79.3%   
Fx outflow Rs m7,3484,889 150.3%   
Net fx Rs m4,71010,312 45.7%   
CASH FLOW
From Operations Rs m6,621-115,975 -5.7%  
From Investments Rs m-6,840-8,265 82.8%  
From Financial Activity Rs m-2,397107,525 -2.2%  
Net Cashflow Rs m-2,612-16,650 15.7%  

Share Holding

Indian Promoters % 40.4 52.9 76.4%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 4.0 210.0%  
FIIs % 10.7 26.6 40.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 16.5 120.6%  
Shareholders   109,995 93,274 117.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   FDC LTD.  UNICHEM LAB  DR. REDDYS LAB  AJANTA PHARMA  ALEMBIC LTD  

Compare BIOCON With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 318 Points Lower; Auto and Metal Stocks Witness Selling(Closing)

India share markets continued to witness selling pressure during closing hours and ended their day on a negative note.

Related Views on News

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

PIRAMAL ENTERPRISES Announces Quarterly Results (4QFY19); Net Profit Down 91.4% (Quarterly Result Update)

Apr 30, 2019 | Updated on Apr 30, 2019

For the quarter ended March 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 3 bn (down 91.4% YoY). Sales on the other hand came in at Rs 37 bn (up 23.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

BIOCON Announces Quarterly Results (4QFY19); Net Profit Down 53.8% (Quarterly Result Update)

Apr 26, 2019 | Updated on Apr 26, 2019

For the quarter ended March 2019, BIOCON has posted a net profit of Rs 705 m (down 53.8% YoY). Sales on the other hand came in at Rs 8 bn (down 34.7% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY19); Net Profit Up 21.8% (Quarterly Result Update)

Jan 30, 2019 | Updated on Jan 30, 2019

For the quarter ended December 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 21.8% YoY). Sales on the other hand came in at Rs 35 bn (up 22.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance(The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

Here's What to Do with Falling Small Cap Stocks(Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Jul 18, 2019 (Close)

TRACK BIOCON

COMPARE BIOCON WITH

MARKET STATS